(Q36235551)

12 August 2017

1 reference

title

Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccines (English)

1 reference

12 August 2017

1 reference

Luis E Raez

1

1 reference

12 August 2017

Edgardo S Santos

series ordinal

2

1 reference

12 August 2017

Raja Mudad

series ordinal

3

1 reference

12 August 2017

Eckhard R Podack

series ordinal

4

1 reference

12 August 2017

language of work or name

1 reference

1 August 2005

1 reference

Expert Review of Anticancer Therapy

12 August 2017

published in

1 reference

12 August 2017

volume

5

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

635-644

1 reference

Revisions in the International System for Staging Lung Cancer

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Cancer vaccines for the treatment and prevention of non small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Origin, maturation and antigen presenting function of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Autologous dendritic cell vaccines for non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Epidermal growth factor-based cancer vaccine for non-small-cell lung cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Lung cancer vaccines and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Heat, heat shock, heat shock proteins and death: a central link in innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.4.635

21 January 2018

Identifiers

DOI

10.1586/14737140.5.4.635

1 reference

12 August 2017

1 reference